Synovus Financial’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Synovus Financial’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-629	Closed	-$77K	–	1592
2020 Q2	$77K	Sell	629 -851	-58%	-$96.5K	﹤0.01%	822
2020 Q1	$128K	Sell	1,480 -124	-8%	-$13.1K	﹤0.01%	866
2019 Q4	$168K	Buy	1,604 +69	+4%	+$7.74K	﹤0.01%	712
2019 Q3	$176K	Buy	1,535 +230	+18%	+$34.9K	﹤0.01%	675
2019 Q2	$225K	Hold	1,305	–	–	﹤0.01%	586
2019 Q1	$220K	Buy	1,305 +535	+69%	+$79.6K	﹤0.01%	563
2018 Q4	$75K	Buy	770 +35	+5%	+$4.59K	﹤0.01%	714
2018 Q3	$127K	Buy	735 +325	+79%	+$46.9K	﹤0.01%	675
2018 Q2	$57K	Buy	+410	New	+$58.2K	﹤0.01%	764

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Synovus Financial's GWPH Position: Q3 2020 in Review

Synovus Financial sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 629 shares — an estimated $77K sold.

Synovus Financial first reported a position in GWPH in Q2 2018 and held it in 9 quarters. The position peaked at $225K in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

Synovus Financial reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Synovus Financial sold 629 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $77K.
Synovus Financial first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 9 quarters.
Synovus Financial's GW Pharmaceuticals Plc American Depositary Shares position peaked at $225K in Q2 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.